Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study

Journal of Drugs in Dermatology, July-August, 2005 by Aditya K. Gupta

2. Evans EG. The rationale for combination therapy. Br J Dermatol. 2001;145 Suppl 60:9-13.

3. Evans EG. Drug synergies and the potential for combination therapy in onychomycosis. Br J Dermatol. 2003;149 Suppl 65:11-13.

4. Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol. 2001;145 Suppl 60:3-8.

5. Olafsson JH, et al. Combination therapy for onychomycosis. Br J Dermatol. 2003;149 Suppl 65:15-18.

6. Gupta AK, Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol. 2003;149:296-305.

7. Gupta AK, Lynch LE. Management of onychomycosis: examining the role of monotherapy, dual, triple, or quadruple therapies. Cutis. 2004;74 (suppl 1):5-9.

8. Seebacher C. Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. Mycoses. 2003;46:506-510.

9. Bohn M, Kraemer KT. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol. 2000;43:S57-S69.

10. Gupta AK, Baran R. Ciclopirox nail lacquer solution 8% in the 21st century. J Am Acad Dermatol. 2000;43:S96-S102.

11. Barchiesi F, et al. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother. 1997;41:1812-1814.

12. Barchiesi F, et al. In vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother. 1998;41:59-65.

13. Baran R, et al. Onychomycosis: the current approach to diagnosis and therapy. Martin Dunitz Ltd., London; 1999:11.

14. De Cuyper C, Hindryckx PH. Long-term outcomes in the treatment of toenail onychomycosis. Br J Dermatol. 1999;141 Suppl 56:15-20.

Aditya K. Gupta MD PhD FRCP(C), (a,b) the Onychomycosis Combination Therapy Study Group

a. Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site) and the University of Toronto, Toronto, Canada

b. Mediprobe Research Inc., London, Ontario, Canada

Address for Correspondence

Aditya K. Gupta MD PhD FRCP(C)

645 Windermere Road

London, Ontario

Canada N5X 2P1

Phone: 519 657 4222

Fax: 519 657 4233

e-mail: agupta@execulink.com